X4 Pharmaceuticals (XFOR) Enterprise Value (2017 - 2026)
X4 Pharmaceuticals (XFOR) reported Enterprise Value of $394.93 million for Q2 2026, compared with -$24.1 million a year earlier and up 29.6% from the prior quarter.
Powered by 
Analysis
X4 Pharmaceuticals (XFOR) Enterprise Value (2017 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, X4 Pharmaceuticals' Enterprise Value came in at -$108.66 million; for FY2025, it came in at -$47.88 million.
- By year, Enterprise Value came in at $69.78 million in FY2024 (-98.4%), $4.38 billion in FY2023 (+147.1%), $1.77 billion in FY2022 (-4.3%) and $1.85 billion in FY2021 (-39.7%).
- The Q2 2026 figure ranks as the highest quarterly Enterprise Value since Q2 2024.
- Year over year, Enterprise Value gained in 1 of the last four quarters, with growth averaging 28.3%.
- The high point for year-over-year Enterprise Value in five years was Q3 2025 (growth of 411.4%); the low point was Q1 2025 (a decline of 100.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $304.66 million (Q1 2026), -$47.88 million (Q4 2025) and $78.36 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | X4 Pharmaceuticals | 381.56 Mn | -317.13 Mn | 7.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 394.93 Mn |
| Mar 31, 2026 | 304.66 Mn |
| Dec 31, 2025 | -47.88 Mn |
| Sep 30, 2025 | 78.36 Mn |
| Jun 30, 2025 | -24.10 Mn |
| Mar 31, 2025 | 727,314.16 |
| Dec 31, 2024 | 69.78 Mn |
| Sep 30, 2024 | 15.32 Mn |
| Jun 30, 2024 | 3.34 Bn |
| Mar 31, 2024 | 8.28 Bn |
| Dec 31, 2023 | 4.38 Bn |
| Sep 30, 2023 | 5.25 Bn |
| Jun 30, 2023 | 9.43 Bn |
| Mar 31, 2023 | 3.10 Bn |
| Dec 31, 2022 | 1.77 Bn |
| Sep 30, 2022 | 3.45 Bn |
| Jun 30, 2022 | 849.80 Mn |
| Mar 31, 2022 | 1.55 Bn |
| Dec 31, 2021 | 1.85 Bn |
| Sep 30, 2021 | 3.84 Bn |
API Access
X4 Pharmaceuticals Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=XFOR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "XFOR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=XFOR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();